The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 3, Pages 568-574
Publisher
Springer Science and Business Media LLC
Online
2022-03-01
DOI
10.1038/s41591-021-01659-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
- (2021) Jasper Tromp et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)
- (2020) Kevin Damman et al. EUROPEAN JOURNAL OF HEART FAILURE
- Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study
- (2020) Jasper Tromp et al. Lancet Global Health
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Serelaxin in Patients with Acute Heart Failure
- (2019) Marco Metra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure
- (2019) Nikola Kozhuharov et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- The stratified win ratio
- (2017) Gaohong Dong et al. Journal of Biopharmaceutical Statistics
- Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
- (2017) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The vulnerable phase after hospitalization for heart failure
- (2015) Stephen J. Greene et al. Nature Reviews Cardiology
- Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
- (2010) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started